These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 11894812)

  • 1. HIV-associated lipodystrophy, metabolic complications, and antiretroviral toxicities.
    Moyle G; Carr A
    HIV Clin Trials; 2002; 3(1):89-98. PubMed ID: 11894812
    [No Abstract]   [Full Text] [Related]  

  • 2. The metabolic puzzle during the evolution of HIV infection.
    Salas-Salvadó J; García-Lorda P
    Clin Nutr; 2001 Oct; 20(5):379-91. PubMed ID: 11534932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipodystrophy and metabolic disorders as complication of antiretroviral therapy of HIV infection.
    Holstein A; Plaschke A; Egberts EH
    Exp Clin Endocrinol Diabetes; 2001; 109(8):389-92. PubMed ID: 11748485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HAART-associated body habitus and metabolic changes, Part 1.
    Liss M; Boyle BA
    AIDS Read; 2000 Nov; 10(11):622, 629-31. PubMed ID: 11186180
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metabolic disorders and lipodystrophy. Adverse effects of antiretroviral therapy].
    Goebel FD; Westner I
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():40-4. PubMed ID: 11373778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic complications of HIV-1 antiretroviral therapy: the lipodystrophy syndrome.
    Borderi M; Verucchi G; Tadolini M; Spinosa S; Fortunato L; Talò S; Chiodo F
    New Microbiol; 2001 Jul; 24(3):303-15. PubMed ID: 11497090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of antiretroviral therapy and implications for drug development.
    Carr A
    Nat Rev Drug Discov; 2003 Aug; 2(8):624-34. PubMed ID: 12904812
    [No Abstract]   [Full Text] [Related]  

  • 8. Switch therapy studies.
    Mallon PW
    J HIV Ther; 2001 May; 6(2):45-8. PubMed ID: 11505945
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic disorders and cardiovascular risk in HIV-infected patients treated with antiretroviral agents.
    Fantoni M; Del Borgo C; Autore C; Barbaro G
    Ital Heart J; 2002 May; 3(5):294-9. PubMed ID: 12066561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shifty fat and bad bones (or, in vivo veritas).
    Mascolini M
    IAPAC Mon; 2000 Nov; 6(11):326-50. PubMed ID: 11299996
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic effects of protease inhibitor therapy.
    Bernasconi E
    AIDS Read; 1999 Jul; 9(4):254-6, 259-60, 266-9. PubMed ID: 12737115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Facial lipodystrophy in patients with HIV infections troublesome to treat].
    Walther RA
    Lakartidningen; 2002 Sep; 99(39):3826-9. PubMed ID: 12395531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic toxicities of antiretroviral therapy.
    Herman JS; Easterbrook PJ
    Int J STD AIDS; 2001 Sep; 12(9):555-62; quiz 563-4. PubMed ID: 11516363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photo quiz. Sunken cheeks.
    Kuwahara RT; Skinner RB
    Am Fam Physician; 2002 Apr; 65(7):1405-6. PubMed ID: 12004789
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diabetic ketoacidosis in an HIV-infected patient undergoing antiretroviral therapy].
    Holm MR; Hansen BR; Røder ME
    Ugeskr Laeger; 2006 Feb; 168(9):920-1. PubMed ID: 16513058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival.
    Leonard EG; McComsey GA
    Infect Dis Clin North Am; 2005 Sep; 19(3):713-29. PubMed ID: 16102657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipodystrophy and metabolic disorders in anti-HIV therapy].
    Behrens GM; Stoll M; Schmidt RE
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():68-71. PubMed ID: 10863318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic toxicities and HIV.
    McGuire S
    Posit Aware; 2002; 13(6):23-5. PubMed ID: 12484331
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metabolic disturbances associated with HAART].
    Olczak A
    Przegl Epidemiol; 2007; 61(4):639-46. PubMed ID: 18572495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Delayed virus suppression has its price. Heart and liver are no longer secondary theaters].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():12-4. PubMed ID: 12043063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.